Spermine prevent iron accumulation and depress lipofuscin accumulation in cultured myocardial cells

Free Radical Biology and Medicine

Volumn 21, Issue 3, 1996, Pages 375-381

  Marzabadi, Massoud R ^a   Løvaas, Erik ^b  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF TROMSØ   (Norway)

Author keywords

Aging; Antioxidant; Deferoaxamine; Fenton reaction; Lipofuscin; Myocyte; Oxygen radicals; Spermine

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; DEFEROXAMINE; DEFEROXAMINE MESYLATE; IRON; LIPOFUSCIN; SPERMINE;

AGING; ANIMAL CELL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENCY; HEART MUSCLE CELL; IRON CHELATION; IRON STORAGE; NEWBORN; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT;

ANIMALIA;

EID: 0029760646     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/0891-5849(96)00038-X     Document Type: Article

References (77)

1. 1. Cutler, R. G. Antioxidants and aging. Am. J. Clin. Nutr. Suppl. 53:373S-379S; 1991.
2. 2. Zs.-Nagy, I. The horizons of an interdisciplinary synthesis in experimental gerontology. Arch. Gerontol. Geriatr. 12:329-349; 1991.
3. 3. Ames, B. N. Dietary carcinogens and anticarcinogens. Science 221:1256-1264; 1983.
4. 4. Vanella, A.; Geremia, E.; Tirido, P.; Monachino, M. E.; Vanella, G.; Marino, M.; Pinturo, R. Superoxide dismutase activity and reduced glutathione content in red blood cells as a function of age. IRCS Med. Sci. Biochem. 10:235-236; 1982.
5. 5. Vanella, A.; Geremia, E.; D'Urso, G.; Tiriolo, P.; Di Silvestro, I.; Grimaldi, R.; Pinturo, R. Superoxide dismutase activities in aging rat brain. Gerontology 28:108-113; 1982.
6. 6. Ames, B. N.; Shigenaga, M. K.; Hagen, T. M. Oxidants, antioxidants, and the degenerative diseases of aging. Proc. Natl. Acad. Sci. USA 90:7915-7922; 1993.
7. 7. Enesco, H. E.; Verdone, S. α-Tocopherol increases life span in the rotifer Philodina. Exp. Gerontol. 15:335-338; 1980.
8. 8. Hazelton, G. A.; Lang, C. A. Glutathione contents of tissues in the aging mouse. Biochem. J. 188:25-30; 1980.
9. 9. Ames, B. N.; Cathcart, R.: Schwiers, E.; Hochstein, P. Uric acid provides an antioxidant defense in humans against oxidant-and radical-caused ageing and cancer: A hypothesis. Proc. Natl. Acad. Sci. USA 78:6858-6862; 1981.
10. 3H mice. Nature 229:254-255; 1971.
11. 11. Løvaas, E. Antioxidative effects of polyamines. J. Am. Oil Chem. Soc. 68:353-358: 1991.
12. 12. Løvaas, E.; Carlin, G. Spermine: An anti-oxidant and anti-inflammatory agent. Free Radic. Biol. Med. 11:455-461; 1991.
13. 13. Tadolini, B. Polyamine inhibition of lipoperoxidation. Biochem. J. 249:33-36; 1988.
14. 14. Schuber, F. Influence of polyamines on membrane function. Biochem. J. 260:1-10; 1989.
15. 15. Tabor, C. W.; Tabor, H. Polyamines. Annu. Rev. Biochem. 53:749-790; 1984.
16. 16. Heby, O. Role of polyamines in the control of cell proliferation and differentiation. Differentiation 19:1-20; 1981.
17. 17. Bueb, J. L.; Mousli, M.; Landry, Y. Modulation of extracellular signal by polyamines through their interactions with receptors, ion channels and G-proteins. In: Caldarera, C. M.; Clô, C.; Moruzzi, M. S. eds. Poylamines: Biological and Clinical Aspects. Bologna: CLUEB; 1994; 1994:97-103.
18. 18. Bueb, J. L.; Da, S. A.; Mousli, M.; Landry . Y. Natural polyamines stimulate G-proteins. Biochem. J. 282:545-550; 1992.
19. 11-(dithiodi-2,1-ethanediyl)bis-1,3-propanediamine (WR-33278). Mutagenesis 9:355-360; 1994.
20. 20. Held, K. D.; Awad, S. Effects of polyamines and thiols on the radiation sensitivity of bacterial transforming DNA. Int. J. Radiat. Biol. 59:699-710; 1991.
21. 21. Gerner, E. W.; Tome, M. E.; Fry, S. E.; Bowden, G. T. Inhibition of ionizing radiation recovery process in polyamine-depleted chinese hamster cells. Cancer Res. 48:4881-4885; 1988.
22. 22. Schaich, K. M. Free radical initiation in proteins and amino acids by ionizing and ultraviolet radiations and lipid oxidation - Part III: Free radical transfer from oxidizing lipids. CRC Crit. Rev. Food Sci. Nutr. 13:188-244; 1980.
23. 23. Davies, K. J. A. Protein damage and degradation by oxygen radicals. I. General aspects. J. Biol. Chem. 262:9895-9901; 1987.
24. 24. Wolff, S. P.; Garner, A.; Dean, R. T. Free radicals, lipids, and protein degradation. Trends Biochem. Sci. 11:27-31; 1986.
25. 25. Brawn, K.; Fridovich, I. DNA strand scission by enzymatically generated oxygen radicals. Arch. Biochem. Biophys. 206(2):414-419: 1981.
26. 26. Richter, C. Reactive oxygen and DNA damage in mitochondria. Mutat. Res. DNAging Genet. Instability Aging 275:249-255; 1992.
27. 28. Grisham, M. B.; Ware, K.; Marshall, S.; Yamada, T.: Sandhu, I. S. Prooxidant properties of 5-aminosalicylic acid. Possible mechanism for its adverse side effects. Dig. Dis. Sci. 37:1383-1389; 1992.
28. 29. Sevanian, A.; Hochstein, P. Mechanisms and consequences of lipid peroxidation in biological systems. Annu. Rev. Nutr. 5:365-390; 1985.
29. 30. Kanner, J.; German, J. B.; Kinsella, J. E. Initiation of lipid peroxidation in biological systems. CRC Crit. Rev. Food Sci. Nutr. 25:317-364; 1987.
30. 31. Esterbauer, H.; Wäg, G.; Puhl, H. Lipid peroxidation and its role in atherosclerosis. Br. Med. Bull. 49:566-576; 1993.
31. 32. Donato, H. J. Age pigments. In: Sohal, R. S. ed. Lipid peroxidation, cross-linked reactions, and aging. Amsterdam: Elsevier; 1981; 1981:63-81.
32. 33. Løvaas, E. Evidence for a proteolytic system i rat liver mitochondria. FEBS Lett. 45:244-247; 1974.
33. 34. Glees, P. Electron microscopic studies on neural lipofuscin: Accumulation and removal. In: Armstrong, D. ed. Ceroid-lipofuscinosis (Battens disease). Amsterdam: Elsevier Medical Press; 1982; 1982:385-395.
34. 35. Dillard, C. J.; Tappel, A. L. Fluorescent products of lipid peroxidation of mitochondria and microsomes. Lipids 6:715-721; 1971.
35. 36. Tappel, A. L.; Fletcher, B. L.; Deamer, D. W. Effects of antioxidants and nutrients on lipid peroxidation fluorescent products and aging parameters in the mouse. J. Gerontol. 28:415-424; 1973.
36. 37. Kikugawa, K.; Beppu, M. Involvement of lipid oxidation products in the formation of fluorescent and cross-linked proteins. Chem. Phys. Lipids 44:277-296; 1987.
37. 38. Gey, K. F. The antioxidant hypothesis of cardiovascular disease: Epidemiology and mechanisms. Biochem. Soc. Trans. 18:1041-1045; 1990.
38. 39. Janero, D. R. Therapeutic potential of vitamin E against myocardial ischemic-reperfusion injury. Free Radic. Biol. Med. 10:315-324; 1991.
39. 40. Bast, A.; Haenen, G. R. M. M.; Doelman, C. J. A. Oxidants and antioxidants: State of the art. Am. J. Med. 91(suppl. 3C):2S-13S; 1991.
40. 41. Galaris. D.; Höijer, B.; Rydström, J. Improved methods for automatic monitoring of contracting heart cells in culture. J. Biochem. Biophys. Methods 2:213-225; 1980.
41. 42. Sohal, R. S.; Marzabadi, M. R.; Galaris, D.; Brunk, U. T. Effect of ambient oxygen concentration on lipofuscin accumulation in cultures rat heart myocytes - A novel in vitro model of lipofuscinogenesis. Free Radic. Biol. Med. 6:23-30; 1989.
42. 43. Zdolsek, J. M.; Roberg, K.; Brunk, U. T. Visualization of iron in cultured macrophages: A cytochemical light and electron microscopic study using autometallography. Free Radic. Biol. Med. 15:1-11; 1993.
43. 44. Danscher, G. Localization of gold in biological tissues. Histochemistry 71:81-88; 1981.
44. 45. Thaw, H. H. Optimal conditions for measurement of lipid peroxidation products (lipofuscin) in individual cultivated human glial and glioma cells. Mech. Ageing Dev. 38:79-87; 1987.
45. 46. Marzabadi, M. R.; Sohal, R. S.; Brunk, U. T. Effect of α-tocopherol and some metal chelators on lipofuscin accumulation in cultured neonatal rat cardiac myocytes. Anal. Cell Pathol. 2:333-346; 1990.
46. 47. Rundquist, I. A flexible system for microscope fluoremetry served by a personal computer. Histochemistry 70:151-159; 1981.
47. 48. Thaw, H. H.; Rundquist, I.; Johansson, U.; Svensson, I.; Collins, V. P. A. A versatile system for multiparametric analysis of cells. Microscopica Acta 87:159-167; 1983.
48. 49. Rundquist, I.; Enerbäck, E. A simple microcomputer system for microscope fluorometry. In: Mize, E. E. ed. The microcomputer in cell and neurobiology research. Amsterdam: Elsevier; 1985; 1985:335-353.
49. 50. Brunk, U. T.; Collins, V. P. A. Lysosomes and age pigments in cultured cells. In: Sohal, R. S. ed. Age pigments. Amsterdam: Elsevier; 1981; 1981:243-264.
50. 51. Deamer, D. W.; Gonzales, J. Autofluorescence structures in cultures WI-38 cells. Arch. Biochem. Biophys. 165:421-426; 1974.
51. 52. Jongkind, J. F.; Verkerk. A.; Visser, W. J.; Dongen, J. M. Isolation of autofluorescent "aged" human fibroblasts by flow sorting. Exp. Cell Res. 138:409-417: 1982.
52. 53. Poot, M.; Visser. W. J.; Jongkind, J. F. Autofluorescence of human skin fibroblasts during growth inhibition and in vitro ageing. Gerontology 31:158-165; 1985.
53. 54. Marzabadi, M. R.; Sohal, R. S.; Brunk, U. T. Effect of ferric iron and desferrioxamine on lipofuscin accumulation in cultured rat heart myocytes. Mech. Ageing Dev.; 1991.
54. 55. Von Zglinicki, T.; Brunk, U. T. Intracellular interactions under oxidative stress and aging: A hypothesis. Z. Gerontol. 26:215-220; 1993.
55. 56. Brunk, U. T.; Jones, C. B.; Sohal, R. S. A novel hypothesis of lipofuscinogenesis and cellular aging based on interactions between oxidative stress and autophagocytosis. Mutat. Res. 275:395-403; 1992.
56. 57. Palmer, B. N.; Powell, H. K. J. Complex formation between 4,9-diazadodecane-1,12-diamine (spermine) and copper(II) ions and protons in aqueous solution. J. C. S. Dalton 2086-2089; 1974.
57. 58. Løvaas, E. Antiinflammatory and metal chelating effect of polyamines. In: Caldarera, C. M.; Clô, C.; Moruzzi, M. S. eds. Polyamines: Biological and clinical aspects. Bologna: Editrice Clueb; 1994; 1994:161-167.
58. 59. Boggs, R.; Donohue, J. Spermine copper(II) perchlorate. Acta Cryst. B31:320-322; 1975.
59. 60. Halliwell, B.; Gutteridge, J. M. C. Oxygen free radicals and iron in relation to biology and medicine: Some problems and concepts. Arch. Biochem. Biophys. 246:501-514; 1986.
60. 61. Holt, S.; Gunderson, M.; Joyce, K. Myocardial tissue iron delocalization and evidence for lipid peroxidation after two hours of ischemia. Ann. Emerg. Med. 15:1155-1159; 1986.
61. 62. Koster, J. F.; Slee, R. G. Ferritin: A physiological iron donor for microsomal lipid peroxidation. FEBS Lett. 199:85-88; 1986.
62. 63. Boucher, F.; Pucheu, S.; Coudray, C.; Favier, A.; De Leiris, J. Evidence of cytosolic iron release during post-ischaemic reperfusion of isolated rat hearts. Influence on spin-trapping experiments with DMPO. FEBS Lett. 302:261-264; 1992.
63. 64. Biemond, P.; Swaak, A. J.; Van Eijk, H. G.; Koster, J. F. Superoxide dependent iron release from ferritin in inflammatory diseases. Free Radic. Biol. Med. 4:185-198; 1988.
64. 65. Jenkins, R. R.; Krause, K.; Schofield, L. S. Influence of exercise on clearance of oxidant stress products and loosely bound iron. Med. Sci. Sports Exerc. 25:213-217; 1993.
65. 66. Voogd, A.; Sluiter, W.; Van Eijk, H. G.; Koster, J. F. Low molecular weight iron and the oxygen paradox in isolated rat hearts. J. Clin. Invest. 90:2050-2055; 1992.
66. 67. Pucheu, S.; Coudray, C.; Tresallet, N.; Favier, A.; De Leiris, J. Effect of iron overload in the isolated ischemic and reperfused rat heart. Cardiovasc. Drugs Ther. 7:701-711; 1993.
67. 68. Karwatowska-Prokopczuk, E.; Czarnowska, E.; Beresewicz, A. Iron availability and free radical induced injury in the isolated ischaemic/reperfused rat heart. Cardiovasc. Res. 26:58-66; 1992.
68. 69. Magnusson, M. K.; Sigfusson, N.; Sigvaldason, H.; Johannesson, G. M.; Magnusson, S.; Thorgeirsson, G. Low iron-binding capacity as a risk factor for myocardial infarction. Circulation 89:102-108; 1994.
69. 70. Bernier, M.; Hearse, D. J.; Manning. A. S. Reperfusion-induced arrhythmias and oxygen-derived free radicals. Circ. Res. 58:331-340; 1986.
70. 71. Jenner, P.; Schapira, A. H. V.; Marsden, C. D. New insights into the cause of Parkinson's disease. Neurology 42:2241-2250; 1992.
71. 72. Palmer, A. M.; Burns, M. A. Selective increase in lipid peroxidation in the inferior temporal cortex in Alzheimer's disease. Brain Res. 645:338-342; 1994.
72. 73. deLemos, R. A.; Roberts, R. J.; Coalson, J. J.; deLemos, J. A.; Null, D. M. J.; Gerstmann, D. R. Toxic effects associated with the administration of deferoxamine in the premature baboon with hyaline membrane disease. Am. J. Dis. Child 144:915-919; 1990.
73. 74. Davis, R. H. Management of polyamine pools and the regulation of ornithine decarboxylase. J. Cell. Biochem. 44:199-205; 1990.
74. 75. Khan, N. A.; Quemener, V.; Moulinoux, J.-P. Polyamine membrane transport regulation. Cell Biol. Int. Rep. 15:9-24; 1991.
75. 76. Gilad, G. M.; Gilad, V. H. Polyamine uptake, binding and release in rat brain. Eur. J. Pharmacol. 193:41-46; 1991.
76. 77. Colombatto, S.; Fulgosi, B.; Bianchi, A.; Massaia, M.; Grillo, M. A. Difference in polyamine transport in human B and T lymphocytes. Biol. Chem. Hoppe Seyler 372:75-78; 1991.
77. 78. Iseki, K.; Kobayashi, M.; Miyazaki, K. Spermine uptake by rat intestinal brush-border membrane vesicles. Biochim. Biophys. Acta Biol-membr. 1068:105-110; 1991.